Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000827034 | SCV000968646 | likely benign | not provided | 2021-04-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001087018 | SCV001025932 | benign | Ehlers-Danlos syndrome, musculocontractural type 2 | 2024-01-07 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000827034 | SCV002497450 | likely benign | not provided | 2022-01-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV001087018 | SCV002808505 | benign | Ehlers-Danlos syndrome, musculocontractural type 2 | 2022-02-10 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003955540 | SCV004767272 | likely benign | DSE-related disorder | 2020-02-10 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |